Literature DB >> 17380163

A polypill for secondary prevention: time to move from intellectual debate to action.

Valentin Fuster, Gines Sanz.   

Abstract

Mesh:

Substances:

Year:  2007        PMID: 17380163     DOI: 10.1038/ncpcardio0858

Source DB:  PubMed          Journal:  Nat Clin Pract Cardiovasc Med        ISSN: 1743-4297


× No keyword cloud information.
  7 in total

Review 1.  Fixed-dose combination therapy and secondary cardiovascular prevention: rationale, selection of drugs and target population.

Authors:  Ginés Sanz; Valentin Fuster
Journal:  Nat Clin Pract Cardiovasc Med       Date:  2008-12-23

Review 2.  Issues to consider in the pharmaceutical development of a cardiovascular polypill.

Authors:  Antonio Guglietta; Marta Guerrero
Journal:  Nat Clin Pract Cardiovasc Med       Date:  2008-12-23

3.  [Cardiovascular disease, renal disease and other chronic diseases. Earlier intervention is needed in chronic renal disease].

Authors:  Ángel Luis Martín de Francisco; Luis Aguilera García; Valentí Fuster Carulla
Journal:  Aten Primaria       Date:  2009-07-24       Impact factor: 1.137

Review 4.  Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey.

Authors:  Richard Kones
Journal:  Drug Des Devel Ther       Date:  2011-06-13       Impact factor: 4.162

5.  New academic partnerships in global health: innovations at Mount Sinai School of Medicine.

Authors:  Philip J Landrigan; Jonathan Ripp; Ramon J C Murphy; Luz Claudio; Jennifer Jao; Braden Hexom; Harrison G Bloom; Taraneh Shirazian; Ebby Elahi; Jeffrey P Koplan
Journal:  Mt Sinai J Med       Date:  2011 May-Jun

6.  Projected impact of polypill use among US adults: Medication use, cardiovascular risk reduction, and side effects.

Authors:  Paul Muntner; Devin Mann; Rachel P Wildman; Daichi Shimbo; Valentin Fuster; Mark Woodward
Journal:  Am Heart J       Date:  2011-04       Impact factor: 4.749

7.  Vibrational Spectroscopic Investigation into Novel Ternary Eutectic Formed between Pyrazinamide, Fumaric Acid, and Isoniazid.

Authors:  Ziming Zhang; Qiqi Wang; Jiadan Xue; Yong Du; Jianjun Liu; Zhi Hong
Journal:  ACS Omega       Date:  2020-07-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.